On September 26th, 2019 the CMDh published the notice “Information on nitrosamines for marketing authorisation holders” asking to all Marketing Authorization Holders (MAHs) of human medicinal products containing chemically synthesised active pharmaceutical ingredients to evaluate the risk of the presence of nitrosamine impurities in their products. This includes generics and over-the counter (OTC) products.
Together we make a better world
We at PQE Group strongly believe that our success is deeply tied to the well-being of the community and the environment in which we live. Therefore, as a corporate, we feel the responsibility to foster the change we wish to see in the World, as Ghandi said.
Discover our main driver and inspiration for taking into action social awareness, environmental sustainability, equality and community empowerment.
PQE Group supports Life Science companies from the Pharmaceutical and the Medical Device industries in every phase of the product lifecycle, offering tailored Quality Solutions deliverable by our specialized team in your language.
Read more below about our services.
Wish to browse our full service catalogue?
Although we at PQE believe in taking actions and not in numbers, we think that the secret to a successful consulting company lies between its people, environment and know-how. These are the features we are most proud of.
A full support for Life Science
In its 20+ years of life, PQE has worked with thousands of clients and always applied the latest technologies and discoveries to help companies achieving their full potential. As an innovation-based agency, we are constantly developing new services and updating our areas of expertise.
Discover the fields we are proficient in.
Discover more about upcoming events and read the latest news from PQE.